Document Detail


Pyruvate prevents restraint-induced immunosuppression via alterations in glucocorticoid responses.
MedLine Citation:
PMID:  15178646     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Stress-evoked immunosuppression may reflect increased demands on cellular energy signaled via elevated glucocorticoid concentrations. We hypothesized that treatment with pyruvate, an alternative energy source, would ameliorate restraint-induced elevation of glucocorticoids and that this reduction in glucocorticoid exposure will prevent stress-induced immunosuppression. We provided exogenous pyruvate to mice exposed to repeated restraint and then assessed splenocyte counts and splenocyte proliferation in response to the mitogen, concanavalin A as well as IgM production in response to keyhole limpet hemocyanin. Immune function was suppressed in mice undergoing repeated restraint but not in mice exposed to repeated restraint followed by pyruvate treatment. All mice exposed to restraint, regardless of pyruvate supplementation, displayed equivalent occurrences of repeated elevations in corticosterone concentrations; however, the cumulative exposure to corticosterone after one episode of restraint was reduced in those mice treated with pyruvate after restraint. Finally, we tested the immunoprotective ability of pyruvate supplementation in the presence of chronically elevated corticosterone. Mice implanted with restraint-like concentrations of corticosterone after adrenalectomy decreased splenocyte counts, compared with either unmanipulated mice or mice that were implanted with a cholesterol pellet after adrenalectomy, regardless of pyruvate supplementation. These data suggest that pyruvate does not possess immunoprotective properties in the presence of chronically elevated corticosterone. Pyruvate supplementation preserves immune function during exposure to repeated restraint stressors; altered dynamics of corticosterone concentrations after pyruvate administration may mediate this immunoprotection. Pyruvate prevents restraint-induced immunosuppression via alterations in the glucocorticoid response to restraint.
Authors:
Gretchen N Neigh; Stephanie L Bowers; Leah M Pyter; Michelle L Gatien; Randy J Nelson
Related Documents :
20692466 - Mice deficient in neuropeptide pacap demonstrate increased sensitivity to in vitro kidn...
9374276 - Effects of oxidative stress on the expression of limbic-specific protease neuropsin and...
21376046 - Hepatitis b virus limits response of human hepatocytes to interferon-α in chimeric mice.
19686806 - Chewing under restraint stress inhibits the stress-induced suppression of cell birth in...
21896326 - Absence of phagocyte nadph oxidase 2 leads to severe inflammatory response in lungs of ...
11508396 - Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antim...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.     Date:  2004-06-03
Journal Detail:
Title:  Endocrinology     Volume:  145     ISSN:  0013-7227     ISO Abbreviation:  Endocrinology     Publication Date:  2004 Sep 
Date Detail:
Created Date:  2004-08-23     Completed Date:  2004-09-28     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0375040     Medline TA:  Endocrinology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4309-19     Citation Subset:  AIM; IM    
Affiliation:
Townshend Hall, 1885 Neil Avenue Mall, Columbus, Ohio 43210, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibody Formation / immunology
Body Weight
Cell Count
Cell Division / immunology
Corticosterone / blood
Corticotropin-Releasing Hormone / metabolism
Glucocorticoids / immunology*
Immune Tolerance / drug effects*,  physiology*
Insulin / blood
Leptin / blood
Male
Mice
Mice, Inbred C57BL
Paraventricular Hypothalamic Nucleus / metabolism
Pyruvic Acid / pharmacology*
Restraint, Physical
Signal Transduction / drug effects,  immunology
Spleen / cytology
Stress, Physiological / immunology*
Grant Support
ID/Acronym/Agency:
MH 6614/MH/NIMH NIH HHS; MH57355/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Glucocorticoids; 0/Leptin; 11061-68-0/Insulin; 127-17-3/Pyruvic Acid; 50-22-6/Corticosterone; 9015-71-8/Corticotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of pituitary tumor transforming gene (PTTG) and its binding protein in human astrocytes a...
Next Document:  The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha ...